Indication
Non-infectious Posterior Uveitis
1 clinical trial
1 product
Clinical trial
A Phase 2 Randomized, Double-Masked, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Active Non-Infectious Intermediate-, Posterior-, and PanuveitisStatus: Active (not recruiting), Estimated PCD: 2024-07-01
Product
Brepocitinib